首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ertugliflozin for type 2 diabetes (vol 42, pg 70, 2019)
被引:0
|
作者
:
不详
论文数:
0
引用数:
0
h-index:
0
不详
机构
:
来源
:
AUSTRALIAN PRESCRIBER
|
2019年
/ 42卷
/ 03期
关键词
:
D O I
:
10.18773/austprescr.2019.036
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:115 / 115
页数:1
相关论文
共 50 条
[31]
Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study (vol 42, pg 514, 2019)
Ceriello, Antonio
论文数:
0
引用数:
0
h-index:
0
Ceriello, Antonio
Rossi, Maria Chiara
论文数:
0
引用数:
0
h-index:
0
Rossi, Maria Chiara
De Cosmo, Salvatore
论文数:
0
引用数:
0
h-index:
0
De Cosmo, Salvatore
Lucisano, Giuseppe
论文数:
0
引用数:
0
h-index:
0
Lucisano, Giuseppe
Pontremoli, Roberto
论文数:
0
引用数:
0
h-index:
0
Pontremoli, Roberto
Fioretto, Paola
论文数:
0
引用数:
0
h-index:
0
Fioretto, Paola
Giorda, Carlo
论文数:
0
引用数:
0
h-index:
0
Giorda, Carlo
Pacilli, Antonio
论文数:
0
引用数:
0
h-index:
0
Pacilli, Antonio
Viazzi, Francesca
论文数:
0
引用数:
0
h-index:
0
Viazzi, Francesca
Russo, Giuseppina
论文数:
0
引用数:
0
h-index:
0
Russo, Giuseppina
Nicolucci, Antonio
论文数:
0
引用数:
0
h-index:
0
Nicolucci, Antonio
[J].
DIABETES CARE,
2020,
43
(02)
: 497
-
497
[32]
Short chain fatty acids, pancreatic dysfunction and type 2 diabetes (vol 19, pg 280, 2019)
Mandaliya, Dipeeka K.
论文数:
0
引用数:
0
h-index:
0
机构:
Nirma Univ, Inst Sci, Ahmadabad 382481, Gujarat, India
Nirma Univ, Inst Sci, Ahmadabad 382481, Gujarat, India
Mandaliya, Dipeeka K.
论文数:
引用数:
h-index:
机构:
Seshadri, Sriram
[J].
PANCREATOLOGY,
2019,
19
(04)
: 616
-
616
[33]
Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes (vol 79, pg 173, 2019)
论文数:
引用数:
h-index:
机构:
Chatterjee, Sudesna
Khunti, Kamlesh
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
Univ Leicester, Univ Hosp Leicester NHS Trust, Leicester, Leics, England
Khunti, Kamlesh
Davies, Melanie J.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Diabet Res Ctr, Leicester, Leics, England
Univ Leicester, Univ Hosp Leicester NHS Trust, Leicester, Leics, England
Davies, Melanie J.
[J].
DRUGS,
2019,
79
(02)
: 187
-
187
[34]
Insulin glargine/lixisenatide in type 2 diabetes: a profile of its use (vol 35, pg 470, 2019)
Deeks, Emma
论文数:
0
引用数:
0
h-index:
0
机构:
Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
Deeks, Emma
[J].
DRUGS & THERAPY PERSPECTIVES,
2019,
35
(12)
: 635
-
635
[35]
Calorie restriction for long-term remission of type 2 diabetes (vol 19, pg 37, 2019)
Taylor, Roy
论文数:
0
引用数:
0
h-index:
0
机构:
Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England
Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England
Taylor, Roy
[J].
CLINICAL MEDICINE,
2019,
19
(02)
: 192
-
192
[36]
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes (vol 17, pg 1521, 2019)
Evans, Marc
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Evans, Marc
Hicks, Debbie
论文数:
0
引用数:
0
h-index:
0
机构:
Medicus Hlth Partners, London, England
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Hicks, Debbie
Patel, Dipesh
论文数:
0
引用数:
0
h-index:
0
机构:
UCL, Div Med, Dept Diabet, Royal Free NHS Trust, London, England
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Patel, Dipesh
Patel, Vinod
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Warwick, Warwick Med Sch, George Eliot Hosp NHS Trust, Nuneaton, England
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Patel, Vinod
McEwan, Phil
论文数:
0
引用数:
0
h-index:
0
机构:
Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
McEwan, Phil
Dashora, Umesh
论文数:
0
引用数:
0
h-index:
0
机构:
East Sussex Healthcare NHS Trust, Eastbourne, England
Univ Hosp Llandough, Diabet Resource Ctr, Cardiff, Wales
Dashora, Umesh
[J].
DIABETES THERAPY,
2020,
11
(02)
: 571
-
571
[37]
Assessment of liver function in patients with type 2 diabetes receiving ertugliflozin
Gallo, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Pharma GmbH, Berlin, Germany
Pfizer Pharma GmbH, Berlin, Germany
Gallo, S.
Calle, R. A.
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Cambridge, MA USA
Pfizer Pharma GmbH, Berlin, Germany
Calle, R. A.
Terra, S. G.
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, Andover, MA USA
Pfizer Pharma GmbH, Berlin, Germany
Terra, S. G.
Pong, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Merck & Co Inc, Kenilworth, NJ USA
Pfizer Pharma GmbH, Berlin, Germany
Pong, A.
Tarasenko, L.
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Inc, New York, NY USA
Pfizer Pharma GmbH, Berlin, Germany
Tarasenko, L.
Raji, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Merck & Co Inc, Kenilworth, NJ USA
Pfizer Pharma GmbH, Berlin, Germany
Raji, A.
[J].
DIABETOLOGIA,
2019,
62
: S341
-
S341
[38]
RETRACTION: Interleukin-1 blockade treatment decreasing cardiovascular risk (vol 42, pg 942, 2019) (Retraction of Vol 42, Pg 942, 2019)
Zheng, Zi-Heng
论文数:
0
引用数:
0
h-index:
0
Zheng, Zi-Heng
[J].
CLINICAL CARDIOLOGY,
2020,
43
(04)
: 410
-
410
[39]
For a 'Sociology as a Team Sport' (vol 70, pg 769, 2019)
Lamont, M.
论文数:
0
引用数:
0
h-index:
0
Lamont, M.
[J].
BRITISH JOURNAL OF SOCIOLOGY,
2019,
70
(04):
: 1633
-
1634
[40]
RETRACTION: CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma (vol 42, pg 67, 2019) (Retraction of Vol 42, Pg 67, 2019)
Liu, Yifei
论文数:
0
引用数:
0
h-index:
0
Liu, Yifei
Bian, Tingting
论文数:
0
引用数:
0
h-index:
0
Bian, Tingting
Feng, Jia
论文数:
0
引用数:
0
h-index:
0
Feng, Jia
Qian, Li
论文数:
0
引用数:
0
h-index:
0
Qian, Li
Li, Xiaoli
论文数:
0
引用数:
0
h-index:
0
Li, Xiaoli
Zhang, Qing
论文数:
0
引用数:
0
h-index:
0
Zhang, Qing
Zhang, Jianguo
论文数:
0
引用数:
0
h-index:
0
Zhang, Jianguo
Jiang, Daishan
论文数:
0
引用数:
0
h-index:
0
Jiang, Daishan
Liu, Jian
论文数:
0
引用数:
0
h-index:
0
Liu, Jian
Shi, Jiahai
论文数:
0
引用数:
0
h-index:
0
Shi, Jiahai
[J].
ONCOLOGY REPORTS,
2023,
50
(02)
←
1
2
3
4
5
→